Skip to main content

Laia Rubio Ortega

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Laia Rubio Ortega

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA

IP: Miguel Chillon Rodriguez
Collaborators: Susana Miravet Delgado, Laia Rubio Ortega, Marina Tarrés Mercader, ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA
Funding agency: Instituto de Salud Carlos III
Funding: 296571
Reference: PMPTA22/00048
Duration: 01/01/2023 - 30/06/2025

Related news

The Gen Rebelde Foundation has made the first donation of the year to the gene therapy research project for GNB1 encephalopathy.

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

Related professionals

Meri Montero Cueto

Meri Montero Cueto

Accounting and Revenue Unit
Finance Directorate
Read more
Pau Torrella Llauger

Pau Torrella Llauger

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Stephen  Mora

Stephen Mora

Neurodegenerative Diseases
Read more
Anas Chaachou Charradi

Anas Chaachou Charradi

Predoctoral researcher
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.